We hypothesized that possession of either of 2 functional coagulation factor XIII polymorphisms , one within subunit A ( Val34Leu ) and one within subunit B ( His95Arg ) , might modulate the prothrombotic effects of estrogen and help to explain the variation in incidence of arterial thrombotic events among postmenopausal women using hormone replacement therapy .